Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa8be03d272a03492b067fcd09cd8e36 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
filingDate |
2003-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a1a0cdd55e142bc44f4e576f31f054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_089673b59471e737f4813009e736ac67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73f7234f48044e8734df9cbc0f508948 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ad602f21813edda5b26d720d1a8aa5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_378157f73033ceea5f91ceb39b497322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2ba715b9b5a13ff82bd3301cbac3bfa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa8dfc5ee471a22d193e1cce10a390fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58303a103376918dfcf372de4daf8e3d |
publicationDate |
2006-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006099660-A1 |
titleOfInvention |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
abstract |
This invention features a method of identifying a compound useful for enhancing efficacy of a therapeutic agent. The method includes incubating a compound in blood cells; separating immune cells from erythrocytic cells; and determining the ratio of the concentration of the compound in the immune cells to the concentration of the compound in the erythrocytic cells; wherein the compound comprises a transportophore and a therapeutic agent, in which the transportophore is covalently bonded to the therapeutic agent via a bond or a linker. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011028417-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357506-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8461120-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009093014-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022332748-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7767797-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009221697-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634411-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11459351-B1 |
priorityDate |
2002-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |